Kanabo issues prospectus for London Stock Exchange after clearance from FCA

An Israeli-founded firm that makes vaporisers is on course to become the first medical cannabis company to float on the London Stock Exchange next month, after regulators gave the green light.

Kanabo set a date of 16 February for its stock market debut and is setting its sights on the UK after securing £6m from investors, valuing the company at £23.2m.

Continue reading…


This post was originally published on this site